Abstract:Purpose: The purpose of the study was to evaluate the midterm and long-term outcomes of patients who underwent thoracic endovascular aortic repair (TEVAR) procedure to treat an uncomplicated acute and subacute type B aortic dissection (uATBAD) with high risk for subsequent aortic complications compared with the group of patients who received a conservative treatment protocol during the same period. Materials and methods: Between 2008 and 2019, 35 patients who had TEVAR due to uATBAD and those with conservative procedure (n=18) were included in a retrospective analysis and follow-up study. The primary endpoints were false lumen thrombosis/perfusion, true lumen diameter, and aortic dilatation. The aortic-related mortality, reintervention, and long-term survival were the secondary endpoints. Results: In the study period, 53 patients (22 females) with a mean age of 61.1±13 years were included. No 30-day and in-hospital mortality was recorded. Permanent neurological deficits occurred in 2 patients (5.7%). In the TEVAR group (n=35) and in a median follow-up period of 34 months, a significant reduction of maximum aortic and false lumen diameter as well as a significant increase of true lumen diameter were detected (p<0.001 each). Complete false lumen thrombosis increased from 6% preoperatively to 60% at follow-up. The median difference in aortic, false lumen, and true lumen diameter was -5 mm (interquartile range [IQR]=-28 to 8 mm), -11 mm (IQR=-53 to 10 mm), and 7 mm (IQR=-13 to 17 mm), respectively. In 3 patients (8.6%), a reintervention was needed. Two patients (1 aortic-related) died during follow-up. The estimated survival according to Kaplan-Meyer analysis was 94.1% after 3 years and 87.5% after 5 years. Similar to the TEVAR group, no 30-day or in-hospital mortality was recorded in the conservative group. During follow-up, 2 patients died and 5 patients underwent conversion-TEVAR (28%). In a median follow-up period of 26 months (range=150), a significant increase of maximum aortic diameter (p=0.006) and a tendency to augmentation of the false lumen (p=0.06) were noted. No significant reduction of the true lumen was seen. Conclusions: Thoracic endovascular aortic repair in patients at high risk of subsequent aortic complications in uncomplicated acute and subacute type B aortic dissection is safe and is associated with favorable midterm outcomes regarding aortic remodeling. Clinical impact: In a retrospective, single center analysis of prospectively collected data with follow-up, we compared 35 patients with high-risk features who recieved TEVAR in acute and sub-acute uncomplicated type B aortic dissection to a control-group (n=18). The TEVAR group showed a significant positive remoduling (reduction of max. aortic and false lumen diameter and increase of true lumen diameter (p<0.001 each)) during follow-up with an estimated survival of 94.1% after 3 years and 87.5% after 5 years.

Outcomes of Selective Strategies for Distal Entry Tears after Thoracic Endovascular Aortic Repair in Type B Aortic Dissection.

Influence of Distal Entry Tears in Acute Type B Aortic Dissection after Thoracic Endovascular Aortic Repair

Long-Term Aortic Remodeling after Thoracic Endovascular Aortic Repair of Acute, Subacute, and Chronic Type B Dissections.

Influence of Primary Intimal Tear Location in Type B Aortic Dissection As a Factor Portending Retrograde Type A Aortic Dissection after Endovascular Repair

Initial Study of the Extended STABILISE Technique for Complete Remodeling in Aortic Dissection

Outcomes and Aortic Remodelling after Proximal Thoracic Endovascular Aortic Repair of Post Type B Aortic Dissection Thoracic Aneurysm

Reintervention after Thoracic Endovascular Aortic Repair of Uncomplicated Type B Aortic Dissection

Prognosis and Remodeling after Endovascular Repair for Acute, Subacute, and Chronic Type B Aortic Dissection.

Favorable Remodeling After TEVAR in Uncomplicated Acute and Subacute Type B Aortic Dissection in Comparison to Conservative Treatment: A Midterm Analysis

Mid-term Outcomes from a Multicenter Study: is TEVAR Safe for Ascending Aortic Dissection?

Mid-Term Outcomes Following TEVAR for Chronic Type B Aortic Dissection

Fate and Consequences of the False Lumen After Thoracic Endovascular Aortic Repair in Type B Aortic Dissection

3D Morphologic Findings Before and after Thoracic Endovascular Aortic Repair for Type B Aortic Dissection

Timing and Outcome of Endovascular Repair for Uncomplicated Type B Aortic Dissection

Application of Antithrombotic Drugs in Patients with Acute Type B Aortic Dissection Underwent Thoracic Endovascular Aortic Repair

[Effects of Thoracic Endovascular Repair in Patients of Type B Aortic Dissection].

Potential Risk Factors of Re-Intervention after Endovascular Repair for Type B Aortic Dissections.

Long-term Results of Thoracic Endovascular Aortic Repair for Type B Aortic Dissection and Risk Factors for Survival

Comparison of thoracic endovascular aortic repair, open surgery and best medical treatment for type B aortic dissection: A meta-analysis

Long-term Outcomes of Thoracic Endovascular Aortic Repair for Chronic Stanford Type B Aortic Dissection

Thoracic Endovascular Aortic Repair for Retrograde Type A Aortic Dissection with an Entry Tear in the Descending Aorta.